Basic/Clinical Science Session
Advances in Multi-Omics Technologies, Including the Robert W. Schrier, MD, Endowed Lectureship
October 24, 2026 | 02:00 PM - 04:00 PM
Location: Mile High Ballroom 4D, Convention Center
Session Description
This session highlights recent advances in multi-omics, spanning genomics, proteomics, metabolomics, and exposomics. Experts showcase innovative tools and study designs that enable integrated, multi-omics analyses to better capture biological complexity and environmental influences in kidney diseases. Emphasis is placed on how these approaches are transforming the discovery of mechanisms of kidney diseases. The session also addresses analytical challenges and future directions for translating multi-omics insights into clinical applications.
ASN gratefully acknowledges Otsuka America Pharmaceutical, Novartis, Astellas Pharma US, and several individuals for support of the Schrier Endowed Lectureship.
Learning Objective(s)
- Describe kidney applications of single-cell genomics
- Distinguish kidney applications of spatial genomics
- Describe kidney applications of spatial metabolomics
- Discuss the field of molecular exposomics
Learning Pathway(s)
- Genetic Diseases and Development
Moderators
Presentations
- Recent Advances in Single-Cell Genomics
02:00 PM - 02:30 PM
- New Methods in Spatial Genomics
02:30 PM - 03:00 PM
- Kidney Applications of Spatial Metabolomics: The Robert W. Schrier, MD, Endowed Lectureship
03:00 PM - 03:30 PM
- What Is Molecular Exposomics?
03:30 PM - 04:00 PM